Status:
COMPLETED
Combination Chemotherapy in Treating Older Patients With Solid Tumour,
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions:
Solid Tumor Regardless of Localization and Stage
Eligibility:
All Genders
75+ years
Phase:
PHASE4
Brief Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination ch...
Detailed Description
OBJECTIVES: Primary * To determine a prognostic scale of the feasibility of chemotherapy (at least two-thirds of the dose intensity usually administered) in patients aged 75 years or older with soli...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed solid tumour regardless of localization or stage
- PATIENT CHARACTERISTICS:
- \> or = 75 years
- patient planned to receive \> or = 2/3 of standard dose of the first cycle
- PRIOR CONCURRENT THERAPY:
- Chemonaive patient.
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
516 Patients enrolled
Trial Details
Trial ID
NCT00664911
Start Date
March 1 2008
End Date
October 1 2013
Last Update
October 16 2013
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Radiotherapie Oncologie Moyenne Garonne
Agen, France, 47000
2
Centre Hospitalier de Castelluccio
Ajaccio, France, 20176
3
Centre Hospitalier d'Ardeche Meridionale
Aubenas, France, 07205
4
Centre Hospitalier d'Auxerre
Auxerre, France, 89011